{"product_id":"ll-37-5mg-vial","title":"LL-37 5mg vial","description":"\u003ch3\u003e\n\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                      \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/h3\u003e\n\u003cp data-start=\"39\" data-end=\"878\"\u003e\u003cstrong\u003eLL-37 \u003c\/strong\u003eis the 37–amino-acid, C-terminal \u003cstrong data-start=\"111\" data-end=\"133\"\u003ehuman cathelicidin\u003c\/strong\u003e peptide generated from the *CAMP* gene product \u003cstrong data-start=\"183\" data-end=\"193\"\u003ehCAP18\u003c\/strong\u003eby proteolysis (e.g., proteinase-3). It is an \u003cstrong data-start=\"240\" data-end=\"292\"\u003eamphipathic α-helical host-defense peptide (HDP)\u003c\/strong\u003e that combines \u003cstrong data-start=\"307\" data-end=\"346\"\u003edirect, rapid microbicidal activity\u003c\/strong\u003e (bacteria, some fungi and enveloped viruses) with \u003cstrong data-start=\"397\" data-end=\"424\"\u003epotent immunomodulation\u003c\/strong\u003e: chemotaxis, dendritic-cell licensing, angiogenesis, epithelial repair, endotoxin neutralization, and biofilm disruption. Unlike conventional antibiotics, LL-37 acts via \u003cstrong data-start=\"595\" data-end=\"642\"\u003emembrane perturbation and immune signalling\u003c\/strong\u003e, reducing classical resistance pressure; however, organisms can adapt (surface charge remodeling, proteases). No LL-37 product is \u003cstrong data-start=\"773\" data-end=\"793\"\u003eFDA\/EMA-approved\u003c\/strong\u003e; several \u003cstrong data-start=\"803\" data-end=\"822\"\u003etopical\/inhaled\u003c\/strong\u003e candidates and \u003cstrong data-start=\"838\" data-end=\"849\"\u003eanalogs\u003c\/strong\u003e are in clinical development.\u003c\/p\u003e\n\u003chr data-start=\"880\" data-end=\"883\"\u003e\n\u003ch3 data-start=\"885\" data-end=\"941\"\u003eAdditional Benefits of LL-37 Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"943\" data-end=\"3471\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"943\" data-end=\"971\"\u003e\n\u003ctr data-start=\"943\" data-end=\"971\"\u003e\n\u003cth data-start=\"943\" data-end=\"953\" data-col-size=\"md\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"953\" data-end=\"971\" data-col-size=\"xl\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"982\" data-end=\"3471\"\u003e\n\u003ctr data-start=\"982\" data-end=\"1305\"\u003e\n\u003ctd data-start=\"982\" data-end=\"1033\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"984\" data-end=\"1032\"\u003e1 Broad-spectrum antimicrobial \u0026amp; antibiofilm\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1033\" data-end=\"1305\" data-col-size=\"xl\"\u003eRapid killing of Gram-positive\/negative bacteria and \u003cstrong data-start=\"1088\" data-end=\"1110\"\u003ebiofilm disruption\u003c\/strong\u003e (including \u003cem data-start=\"1122\" data-end=\"1137\"\u003eP. aeruginosa\u003c\/em\u003e, \u003cem data-start=\"1139\" data-end=\"1150\"\u003eS. aureus\u003c\/em\u003e), with \u003cstrong data-start=\"1158\" data-end=\"1169\"\u003esynergy\u003c\/strong\u003e to β-lactams, glycopeptides, and quinolones. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Antimicrobial Agents \u0026amp; Chemotherapy; Journal of Antimicrobial Chemotherapy\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1306\" data-end=\"1525\"\u003e\n\u003ctd data-start=\"1306\" data-end=\"1349\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1308\" data-end=\"1348\"\u003e2 Endotoxin (LPS\/LTA) neutralization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1349\" data-end=\"1525\" data-col-size=\"xl\"\u003eDirect binding to \u003cstrong data-start=\"1369\" data-end=\"1380\"\u003eLPS\/LTA\u003c\/strong\u003e blunts TLR4\/2 signalling → lower \u003cstrong data-start=\"1414\" data-end=\"1428\"\u003eTNF-α\/IL-6\u003c\/strong\u003e; improves survival surrogates in endotoxemia models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Infection \u0026amp; Immunity; Shock\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1526\" data-end=\"1811\"\u003e\n\u003ctd data-start=\"1526\" data-end=\"1571\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1528\" data-end=\"1570\"\u003e3 Wound healing \u0026amp; re-epithelialization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1571\" data-end=\"1811\" data-col-size=\"xl\"\u003eStimulates \u003cstrong data-start=\"1584\" data-end=\"1610\"\u003ekeratinocyte migration\u003c\/strong\u003e, \u003cstrong data-start=\"1612\" data-end=\"1635\"\u003eangiogenesis (VEGF)\u003c\/strong\u003e, and \u003cstrong data-start=\"1641\" data-end=\"1663\"\u003egranulation tissue\u003c\/strong\u003e, accelerating closure of \u003cstrong data-start=\"1689\" data-end=\"1715\"\u003evenous\/diabetic ulcers\u003c\/strong\u003e in early clinical studies. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Wound Repair \u0026amp; Regeneration; The Lancet EBioMedicine\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1812\" data-end=\"2078\"\u003e\n\u003ctd data-start=\"1812\" data-end=\"1859\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1814\" data-end=\"1858\"\u003e4 Antiviral activity (enveloped viruses)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1859\" data-end=\"2078\" data-col-size=\"xl\"\u003eInterferes with \u003cstrong data-start=\"1877\" data-end=\"1896\"\u003eviral envelopes\u003c\/strong\u003e and enhances \u003cstrong data-start=\"1910\" data-end=\"1936\"\u003einnate antiviral genes\u003c\/strong\u003e; in vitro activity vs influenza\/RSV\/coronaviruses; clinical translation ongoing. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Virology; Frontiers in Immunology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2079\" data-end=\"2355\"\u003e\n\u003ctd data-start=\"2079\" data-end=\"2112\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2081\" data-end=\"2111\"\u003e5 Respiratory host defense\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2112\" data-end=\"2355\" data-col-size=\"xl\"\u003eAugments \u003cstrong data-start=\"2123\" data-end=\"2152\"\u003eairway epithelial barrier\u003c\/strong\u003e, mucus clearance, and bacterial clearance; inhaled\/neb formulations under study for \u003cstrong data-start=\"2237\" data-end=\"2258\"\u003eCF\/bronchiectasis\u003c\/strong\u003e colonization. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;American Journal of Respiratory Cell and Molecular Biology; Thorax\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2356\" data-end=\"2635\"\u003e\n\u003ctd data-start=\"2356\" data-end=\"2396\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2358\" data-end=\"2395\"\u003e6 Dental\/periodontal applications\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2396\" data-end=\"2635\" data-col-size=\"xl\"\u003eReduces periodontal pathogens and biofilms; promotes \u003cstrong data-start=\"2451\" data-end=\"2474\"\u003egingival fibroblast\u003c\/strong\u003e repair—evaluated as a \u003cstrong data-start=\"2497\" data-end=\"2526\"\u003elocally delivered adjunct\u003c\/strong\u003e to scaling\/root planing. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Clinical Periodontology; Journal of Periodontal Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2636\" data-end=\"2871\"\u003e\n\u003ctd data-start=\"2636\" data-end=\"2681\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2638\" data-end=\"2680\"\u003e7 Ophthalmology (infectious keratitis)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2681\" data-end=\"2871\" data-col-size=\"xl\"\u003eTopical LL-37 analogs enhance \u003cstrong data-start=\"2713\" data-end=\"2743\"\u003ecorneal epithelial healing\u003c\/strong\u003e and reduce microbial load in preclinical keratitis models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Investigative Ophthalmology \u0026amp; Visual Science; Cornea\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2872\" data-end=\"3148\"\u003e\n\u003ctd data-start=\"2872\" data-end=\"2912\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2874\" data-end=\"2911\"\u003e8 Anti-inflammatory immune tuning\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2912\" data-end=\"3148\" data-col-size=\"xl\"\u003eContext-dependent modulation: boosts \u003cstrong data-start=\"2951\" data-end=\"2980\"\u003echemotaxis (via FPR2\/ALX)\u003c\/strong\u003e and \u003cstrong data-start=\"2985\" data-end=\"3002\"\u003eNET clearance\u003c\/strong\u003e, yet can \u003cstrong data-start=\"3012\" data-end=\"3037\"\u003elimit excessive NF-κB\u003c\/strong\u003e activation—useful in chronic inflammatory wounds. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Nature Communications; Journal of Immunology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3149\" data-end=\"3471\"\u003e\n\u003ctd data-start=\"3149\" data-end=\"3190\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"3151\" data-end=\"3189\"\u003e9 Oncology (bidirectional signals)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3190\" data-end=\"3471\" data-col-size=\"xl\"\u003eAt micromolar ranges, LL-37 can be \u003cstrong data-start=\"3227\" data-end=\"3243\"\u003eanti-tumoral\u003c\/strong\u003e (membranolysis, immune activation) in some cancers, yet \u003cstrong data-start=\"3300\" data-end=\"3315\"\u003epro-tumoral\u003c\/strong\u003e in others (e.g., pro-angiogenic in certain epithelial tumors); applications focus on \u003cstrong data-start=\"3401\" data-end=\"3428\"\u003etumor-selective analogs\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Cancer Research; Oncogene\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3473\" data-end=\"3476\"\u003e\n\u003ch2 data-start=\"3478\" data-end=\"3513\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"3515\" data-end=\"3553\"\u003e2.1 Pharmacodynamics \/ Receptors\u003c\/h3\u003e\n\u003cul data-start=\"3554\" data-end=\"4129\"\u003e\n\u003cli data-start=\"3554\" data-end=\"3678\"\u003e\n\u003cp data-start=\"3556\" data-end=\"3678\"\u003e\u003cstrong data-start=\"3556\" data-end=\"3581\"\u003eDirect antimicrobial:\u003c\/strong\u003e Amphipathic helix inserts into microbial membranes → \u003cstrong data-start=\"3635\" data-end=\"3650\"\u003ecarpet\/pore\u003c\/strong\u003e mechanisms → rapid lysis.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3679\" data-end=\"3777\"\u003e\n\u003cp data-start=\"3681\" data-end=\"3777\"\u003e\u003cstrong data-start=\"3681\" data-end=\"3708\"\u003ePattern neutralization:\u003c\/strong\u003e Binds \u003cstrong data-start=\"3715\" data-end=\"3726\"\u003eLPS\/LTA\u003c\/strong\u003e and nucleic acids, reducing TLR over-activation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3778\" data-end=\"3955\"\u003e\n\u003cp data-start=\"3780\" data-end=\"3955\"\u003e\u003cstrong data-start=\"3780\" data-end=\"3801\"\u003eImmunomodulation:\u003c\/strong\u003e Engages \u003cstrong data-start=\"3810\" data-end=\"3822\"\u003eFPR2\/ALX\u003c\/strong\u003e, \u003cstrong data-start=\"3824\" data-end=\"3832\"\u003eP2X7\u003c\/strong\u003e, and transactivates \u003cstrong data-start=\"3853\" data-end=\"3861\"\u003eEGFR\u003c\/strong\u003e on epithelia; chemoattracts \u003cstrong data-start=\"3890\" data-end=\"3925\"\u003eneutrophils, monocytes, T cells\u003c\/strong\u003e; promotes \u003cstrong data-start=\"3936\" data-end=\"3952\"\u003eangiogenesis\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3956\" data-end=\"4129\"\u003e\n\u003cp data-start=\"3958\" data-end=\"4129\"\u003e\u003cstrong data-start=\"3958\" data-end=\"3983\"\u003eAutoimmunity context:\u003c\/strong\u003e Complexes with self-DNA\/RNA can trigger \u003cstrong data-start=\"4024\" data-end=\"4038\"\u003epDC TLR9\/7\u003c\/strong\u003e and type-I IFN—implicated in \u003cstrong data-start=\"4068\" data-end=\"4081\"\u003epsoriasis\u003c\/strong\u003e pathogenesis (caution in susceptible patients).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"4131\" data-end=\"4158\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"4160\" data-end=\"4684\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"4160\" data-end=\"4202\"\u003e\n\u003ctr data-start=\"4160\" data-end=\"4202\"\u003e\n\u003cth data-start=\"4160\" data-end=\"4170\" data-col-size=\"sm\"\u003ePathway\u003c\/th\u003e\n\u003cth data-start=\"4170\" data-end=\"4191\" data-col-size=\"md\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"4191\" data-end=\"4202\" data-col-size=\"sm\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"4217\" data-end=\"4684\"\u003e\n\u003ctr data-start=\"4217\" data-end=\"4317\"\u003e\n\u003ctd data-start=\"4217\" data-end=\"4245\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4219\" data-end=\"4244\"\u003eMembrane perturbation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4245\" data-end=\"4295\" data-col-size=\"md\"\u003eBactericidal, antifungal, antiviral (enveloped)\u003c\/td\u003e\n\u003ctd data-start=\"4295\" data-end=\"4317\" data-col-size=\"sm\"\u003ePathogens\/biofilms\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4318\" data-end=\"4406\"\u003e\n\u003ctd data-start=\"4318\" data-end=\"4352\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4320\" data-end=\"4351\"\u003eTLR decoy (LPS\/LTA binding)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4352\" data-end=\"4376\" data-col-size=\"md\"\u003e↓ NF-κB, ↓ TNF-α\/IL-6\u003c\/td\u003e\n\u003ctd data-start=\"4376\" data-end=\"4406\" data-col-size=\"sm\"\u003eSepsis\/endotoxemia, wounds\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4407\" data-end=\"4505\"\u003e\n\u003ctd data-start=\"4407\" data-end=\"4433\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4409\" data-end=\"4432\"\u003eFPR2\/ALX signalling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4433\" data-end=\"4477\" data-col-size=\"md\"\u003eChemotaxis, angiogenesis, resolution cues\u003c\/td\u003e\n\u003ctd data-start=\"4477\" data-end=\"4505\" data-col-size=\"sm\"\u003eNeutrophils, endothelium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4506\" data-end=\"4595\"\u003e\n\u003ctd data-start=\"4506\" data-end=\"4533\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4508\" data-end=\"4532\"\u003eEGFR transactivation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4533\" data-end=\"4580\" data-col-size=\"md\"\u003eKeratinocyte migration, re-epithelialization\u003c\/td\u003e\n\u003ctd data-start=\"4580\" data-end=\"4595\" data-col-size=\"sm\"\u003eSkin\/cornea\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4596\" data-end=\"4684\"\u003e\n\u003ctd data-start=\"4596\" data-end=\"4624\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4598\" data-end=\"4623\"\u003eP2X7 \u0026amp; NET modulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4624\" data-end=\"4665\" data-col-size=\"md\"\u003eNET clearance, controlled inflammasome\u003c\/td\u003e\n\u003ctd data-start=\"4665\" data-end=\"4684\" data-col-size=\"sm\"\u003eInnate immunity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"4686\" data-end=\"4689\"\u003e\n\u003ch2 data-start=\"4691\" data-end=\"4713\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-start=\"4715\" data-end=\"5271\"\u003e\n\u003cli data-start=\"4715\" data-end=\"4853\"\u003e\n\u003cp data-start=\"4717\" data-end=\"4853\"\u003e\u003cstrong data-start=\"4717\" data-end=\"4740\"\u003eRoute\/formulations:\u003c\/strong\u003e \u003cstrong data-start=\"4741\" data-end=\"4764\"\u003eTopical gels\/creams\u003c\/strong\u003e, \u003cstrong data-start=\"4766\" data-end=\"4785\"\u003ewound dressings\u003c\/strong\u003e, \u003cstrong data-start=\"4787\" data-end=\"4809\"\u003eintranasal\/inhaled\u003c\/strong\u003e aerosols; parenteral use is experimental.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4854\" data-end=\"5047\"\u003e\n\u003cp data-start=\"4856\" data-end=\"5047\"\u003e\u003cstrong data-start=\"4856\" data-end=\"4870\"\u003eHalf-life:\u003c\/strong\u003e Short \u003cstrong data-start=\"4877\" data-end=\"4894\"\u003eminutes–hours\u003c\/strong\u003e in protease-rich environments (wounds, lung); activity extended by \u003cstrong data-start=\"4962\" data-end=\"4998\"\u003ehydrogels, liposomes, PEGylation\u003c\/strong\u003e, \u003cstrong data-start=\"5000\" data-end=\"5024\"\u003eD-amino-acid analogs\u003c\/strong\u003e, or \u003cstrong data-start=\"5029\" data-end=\"5044\"\u003ecyclization\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5048\" data-end=\"5170\"\u003e\n\u003cp data-start=\"5050\" data-end=\"5170\"\u003e\u003cstrong data-start=\"5050\" data-end=\"5067\"\u003eDistribution:\u003c\/strong\u003e Predominantly \u003cstrong data-start=\"5082\" data-end=\"5091\"\u003elocal\u003c\/strong\u003e at administration site; strong binding to \u003cstrong data-start=\"5134\" data-end=\"5142\"\u003eGAGs\u003c\/strong\u003e and extracellular matrix.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5171\" data-end=\"5271\"\u003e\n\u003cp data-start=\"5173\" data-end=\"5271\"\u003e\u003cstrong data-start=\"5173\" data-end=\"5187\"\u003eClearance:\u003c\/strong\u003e Proteolysis (neutrophil elastase, trypsin-like proteases); minimal CYP involvement.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5273\" data-end=\"5276\"\u003e\n\u003ch2 data-start=\"5278\" data-end=\"5323\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"5325\" data-end=\"5349\"\u003e4.1 Chronic Wounds\u003c\/h3\u003e\n\u003cp data-start=\"5350\" data-end=\"5568\"\u003eTopical LL-37\/analogs improved \u003cstrong data-start=\"5381\" data-end=\"5398\"\u003ehealing rates\u003c\/strong\u003e and \u003cstrong data-start=\"5403\" data-end=\"5422\"\u003etime-to-closure\u003c\/strong\u003e in small RCTs of \u003cstrong data-start=\"5440\" data-end=\"5461\"\u003evenous leg ulcers\u003c\/strong\u003e and pilot \u003cstrong data-start=\"5472\" data-end=\"5495\"\u003ediabetic foot ulcer\u003c\/strong\u003e studies; reductions in bioburden and improved granulation were reported.\u003c\/p\u003e\n\u003ch3 data-start=\"5570\" data-end=\"5597\"\u003e4.2 ENT \/ Respiratory\u003c\/h3\u003e\n\u003cp data-start=\"5598\" data-end=\"5795\"\u003e\u003cstrong data-start=\"5598\" data-end=\"5608\"\u003eOP-145\u003c\/strong\u003e (LL-37-derived) showed clinical signals in \u003cstrong data-start=\"5652\" data-end=\"5688\"\u003echronic suppurative otitis media\u003c\/strong\u003e; intranasal\/inhaled candidates reduce pathogen burden and mucus viscosity in \u003cstrong data-start=\"5766\" data-end=\"5787\"\u003eCF\/bronchiectasis\u003c\/strong\u003e models.\u003c\/p\u003e\n\u003ch3 data-start=\"5797\" data-end=\"5816\"\u003e4.3 Dentistry\u003c\/h3\u003e\n\u003cp data-start=\"5817\" data-end=\"5958\"\u003eLocally delivered LL-37 adjuncts improved \u003cstrong data-start=\"5859\" data-end=\"5888\"\u003eclinical attachment level\u003c\/strong\u003e and reduced \u003cstrong data-start=\"5901\" data-end=\"5920\"\u003epathogen counts\u003c\/strong\u003e vs debridement alone in early trials.\u003c\/p\u003e\n\u003ch3 data-start=\"5960\" data-end=\"5985\"\u003e4.4 Antiviral \/ ARI\u003c\/h3\u003e\n\u003cp data-start=\"5986\" data-end=\"6143\"\u003eIn vitro inhibition of influenza and coronaviruses; small, phenotype-selected trials are exploring \u003cstrong data-start=\"6085\" data-end=\"6101\"\u003eupper-airway\u003c\/strong\u003e symptom duration and viral load outcomes.\u003c\/p\u003e\n\u003cblockquote data-start=\"6145\" data-end=\"6302\"\u003e\n\u003cp data-start=\"6147\" data-end=\"6302\"\u003e\u003cstrong data-start=\"6147\" data-end=\"6173\"\u003eEvidence quality note:\u003c\/strong\u003e Many studies are \u003cstrong data-start=\"6191\" data-end=\"6212\"\u003eearly-phase\/small\u003c\/strong\u003e; heterogeneity in peptide versions, delivery systems, and endpoints remains a limitation.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"6304\" data-end=\"6307\"\u003e\n\u003ch2 data-start=\"6309\" data-end=\"6342\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"6344\" data-end=\"7084\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"6344\" data-end=\"6382\"\u003e\n\u003ctr data-start=\"6344\" data-end=\"6382\"\u003e\n\u003cth data-start=\"6344\" data-end=\"6352\" data-col-size=\"sm\"\u003eField\u003c\/th\u003e\n\u003cth data-start=\"6352\" data-end=\"6364\" data-col-size=\"md\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"6364\" data-end=\"6382\" data-col-size=\"sm\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6397\" data-end=\"7084\"\u003e\n\u003ctr data-start=\"6397\" data-end=\"6504\"\u003e\n\u003ctd data-start=\"6397\" data-end=\"6428\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6399\" data-end=\"6427\"\u003eChronic wounds (DFU\/VLU)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6428\" data-end=\"6468\" data-col-size=\"md\"\u003eAntibiofilm + pro-healing dual action\u003c\/td\u003e\n\u003ctd data-start=\"6468\" data-end=\"6504\" data-col-size=\"sm\"\u003ePhase 1\/2; device-drug dressings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6505\" data-end=\"6604\"\u003e\n\u003ctd data-start=\"6505\" data-end=\"6542\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6507\" data-end=\"6541\"\u003eCF\/bronchiectasis colonization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6542\" data-end=\"6572\" data-col-size=\"md\"\u003eInhaled antibiofilm therapy\u003c\/td\u003e\n\u003ctd data-start=\"6572\" data-end=\"6604\" data-col-size=\"sm\"\u003eTranslational\/early clinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6605\" data-end=\"6704\"\u003e\n\u003ctd data-start=\"6605\" data-end=\"6628\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6607\" data-end=\"6627\"\u003eCRS\/otitis media\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6628\" data-end=\"6678\" data-col-size=\"md\"\u003eTopical anti-infective with low resistance risk\u003c\/td\u003e\n\u003ctd data-start=\"6678\" data-end=\"6704\" data-col-size=\"sm\"\u003eSmall clinical studies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6705\" data-end=\"6789\"\u003e\n\u003ctd data-start=\"6705\" data-end=\"6735\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6707\" data-end=\"6734\"\u003ePeriodontitis\/mucositis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6735\" data-end=\"6773\" data-col-size=\"md\"\u003eLocal antimicrobial + tissue repair\u003c\/td\u003e\n\u003ctd data-start=\"6773\" data-end=\"6789\" data-col-size=\"sm\"\u003ePilot trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6790\" data-end=\"6892\"\u003e\n\u003ctd data-start=\"6790\" data-end=\"6817\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6792\" data-end=\"6816\"\u003eOphthalmic keratitis\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6817\" data-end=\"6851\" data-col-size=\"md\"\u003eCorneal healing + antimicrobial\u003c\/td\u003e\n\u003ctd data-start=\"6851\" data-end=\"6892\" data-col-size=\"sm\"\u003ePreclinical → early human feasibility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6893\" data-end=\"6986\"\u003e\n\u003ctd data-start=\"6893\" data-end=\"6914\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6895\" data-end=\"6913\"\u003eSepsis adjunct\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6914\" data-end=\"6957\" data-col-size=\"md\"\u003e\n\u003cstrong data-start=\"6916\" data-end=\"6938\"\u003eLPS neutralization\u003c\/strong\u003e and immune tuning\u003c\/td\u003e\n\u003ctd data-start=\"6957\" data-end=\"6986\" data-col-size=\"sm\"\u003ePreclinical\/observational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6987\" data-end=\"7084\"\u003e\n\u003ctd data-start=\"6987\" data-end=\"7014\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6989\" data-end=\"7013\"\u003eOncology (selective)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7014\" data-end=\"7056\" data-col-size=\"md\"\u003eTumor-targeted cytolysis\/immune priming\u003c\/td\u003e\n\u003ctd data-start=\"7056\" data-end=\"7084\" data-col-size=\"sm\"\u003ePreclinical optimization\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"7086\" data-end=\"7089\"\u003e\n\u003ch2 data-start=\"7091\" data-end=\"7120\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"7122\" data-end=\"7726\"\u003e\n\u003cli data-start=\"7122\" data-end=\"7204\"\u003e\n\u003cp data-start=\"7124\" data-end=\"7204\"\u003e\u003cstrong data-start=\"7124\" data-end=\"7145\"\u003eCommon (topical):\u003c\/strong\u003e Mild \u003cstrong data-start=\"7151\" data-end=\"7163\"\u003estinging\u003c\/strong\u003e, \u003cstrong data-start=\"7165\" data-end=\"7177\"\u003eerythema\u003c\/strong\u003e, transient \u003cstrong data-start=\"7189\" data-end=\"7201\"\u003epruritus\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7205\" data-end=\"7314\"\u003e\n\u003cp data-start=\"7207\" data-end=\"7314\"\u003e\u003cstrong data-start=\"7207\" data-end=\"7250\"\u003eSystemic\/respiratory (investigational):\u003c\/strong\u003e Occasional \u003cstrong data-start=\"7262\" data-end=\"7292\"\u003ecough\/bronchial irritation\u003c\/strong\u003e with inhaled forms.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7315\" data-end=\"7426\"\u003e\n\u003cp data-start=\"7317\" data-end=\"7426\"\u003e\u003cstrong data-start=\"7317\" data-end=\"7341\"\u003eCytotoxicity window:\u003c\/strong\u003e High micromolar levels can injure host cells—necessitates \u003cstrong data-start=\"7400\" data-end=\"7423\"\u003econtrolled delivery\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7427\" data-end=\"7564\"\u003e\n\u003cp data-start=\"7429\" data-end=\"7564\"\u003e\u003cstrong data-start=\"7429\" data-end=\"7452\"\u003eAutoimmune caution:\u003c\/strong\u003e LL-37–nucleic acid complexes may \u003cstrong data-start=\"7486\" data-end=\"7510\"\u003eexacerbate psoriasis\u003c\/strong\u003e\/\u003cstrong data-start=\"7511\" data-end=\"7525\"\u003elupus-like\u003c\/strong\u003e pathways in predisposed individuals.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7565\" data-end=\"7726\"\u003e\n\u003cp data-start=\"7567\" data-end=\"7726\"\u003e\u003cstrong data-start=\"7567\" data-end=\"7582\"\u003eMicrobiome:\u003c\/strong\u003e More \u003cstrong data-start=\"7588\" data-end=\"7599\"\u003esparing\u003c\/strong\u003e than broad antiseptics; resistance risk exists (charge remodeling, proteases) but is \u003cstrong data-start=\"7685\" data-end=\"7704\"\u003elower\/different\u003c\/strong\u003e than for antibiotics.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"7728\" data-end=\"7757\"\u003e\u003cstrong data-start=\"7728\" data-end=\"7757\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"7759\" data-end=\"8339\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"7759\" data-end=\"7888\"\u003e\n\u003ctr data-start=\"7759\" data-end=\"7888\"\u003e\n\u003cth data-start=\"7759\" data-end=\"7769\" data-col-size=\"sm\"\u003eConcern\u003c\/th\u003e\n\u003cth data-start=\"7769\" data-end=\"7804\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7771\" data-end=\"7803\"\u003eLL-37 (host-defense peptide)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7804\" data-end=\"7847\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7806\" data-end=\"7846\"\u003eTopical antibiotic (e.g., mupirocin)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7847\" data-end=\"7888\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7849\" data-end=\"7886\"\u003eAntiseptic (chlorhexidine\/silver)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"7907\" data-end=\"8339\"\u003e\n\u003ctr data-start=\"7907\" data-end=\"7967\"\u003e\n\u003ctd data-start=\"7907\" data-end=\"7929\" data-col-size=\"sm\"\u003eBiofilm penetration\u003c\/td\u003e\n\u003ctd data-start=\"7929\" data-end=\"7940\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7931\" data-end=\"7939\"\u003eHigh\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7940\" data-end=\"7951\" data-col-size=\"sm\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-start=\"7951\" data-end=\"7967\" data-col-size=\"sm\"\u003eLow–moderate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7968\" data-end=\"8077\"\u003e\n\u003ctd data-start=\"7968\" data-end=\"7991\" data-col-size=\"sm\"\u003eResistance selection\u003c\/td\u003e\n\u003ctd data-start=\"7991\" data-end=\"8026\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7993\" data-end=\"8025\"\u003eLow–moderate (non-classical)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"8026\" data-end=\"8046\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8028\" data-end=\"8045\"\u003eModerate–high\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"8046\" data-end=\"8077\" data-col-size=\"sm\"\u003eLow (but cytotoxic broadly)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8078\" data-end=\"8170\"\u003e\n\u003ctd data-start=\"8078\" data-end=\"8102\" data-col-size=\"sm\"\u003eTissue repair effects\u003c\/td\u003e\n\u003ctd data-start=\"8102\" data-end=\"8131\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8104\" data-end=\"8130\"\u003ePro-healing\/angiogenic\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"8131\" data-end=\"8141\" data-col-size=\"sm\"\u003eNeutral\u003c\/td\u003e\n\u003ctd data-start=\"8141\" data-end=\"8170\" data-col-size=\"sm\"\u003eOften inhibitory\/irritant\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8171\" data-end=\"8240\"\u003e\n\u003ctd data-start=\"8171\" data-end=\"8195\" data-col-size=\"sm\"\u003eMicrobiome disruption\u003c\/td\u003e\n\u003ctd data-start=\"8195\" data-end=\"8207\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8197\" data-end=\"8206\"\u003eLower\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"8207\" data-end=\"8218\" data-col-size=\"sm\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-start=\"8218\" data-end=\"8240\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8220\" data-end=\"8238\"\u003eHigher (broad)\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"8241\" data-end=\"8339\"\u003e\n\u003ctd data-start=\"8241\" data-end=\"8264\" data-col-size=\"sm\"\u003eIrritation potential\u003c\/td\u003e\n\u003ctd data-start=\"8264\" data-end=\"8297\" data-col-size=\"sm\"\u003eMild–moderate (dose-dependent)\u003c\/td\u003e\n\u003ctd data-start=\"8297\" data-end=\"8303\" data-col-size=\"sm\"\u003eLow\u003c\/td\u003e\n\u003ctd data-start=\"8303\" data-end=\"8339\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"8305\" data-end=\"8337\"\u003eVariable; can be significant\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"8341\" data-end=\"8344\"\u003e\n\u003ch2 data-start=\"8346\" data-end=\"8372\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"8374\" data-end=\"8732\"\u003e\n\u003cli data-start=\"8374\" data-end=\"8414\"\u003e\n\u003cp data-start=\"8376\" data-end=\"8414\"\u003e\u003cstrong data-start=\"8376\" data-end=\"8390\"\u003eApprovals:\u003c\/strong\u003e None (major markets).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8415\" data-end=\"8610\"\u003e\n\u003cp data-start=\"8417\" data-end=\"8610\"\u003e\u003cstrong data-start=\"8417\" data-end=\"8439\"\u003eClinical programs:\u003c\/strong\u003e \u003cstrong data-start=\"8440\" data-end=\"8466\"\u003eTopical gels\/dressings\u003c\/strong\u003e and \u003cstrong data-start=\"8471\" data-end=\"8488\"\u003einhaled\/nasal\u003c\/strong\u003e formulations in early trials; \u003cstrong data-start=\"8519\" data-end=\"8544\"\u003eLL-37-derived analogs\u003c\/strong\u003e(e.g., OP-145, SAAP-class) advancing as \u003cstrong data-start=\"8585\" data-end=\"8607\"\u003eantibiofilm agents\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8611\" data-end=\"8732\"\u003e\n\u003cp data-start=\"8613\" data-end=\"8732\"\u003e\u003cstrong data-start=\"8613\" data-end=\"8631\"\u003eManufacturing:\u003c\/strong\u003e Peptide synthesis under \u003cstrong data-start=\"8656\" data-end=\"8663\"\u003eGMP\u003c\/strong\u003e; stability and protease susceptibility drive formulation innovation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"8734\" data-end=\"8737\"\u003e\n\u003ch2 data-start=\"8739\" data-end=\"8762\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-start=\"8764\" data-end=\"9441\"\u003e\n\u003cli data-start=\"8764\" data-end=\"8900\"\u003e\n\u003cp data-start=\"8766\" data-end=\"8900\"\u003e\u003cstrong data-start=\"8766\" data-end=\"8794\"\u003eFormulation engineering:\u003c\/strong\u003e \u003cstrong data-start=\"8795\" data-end=\"8825\"\u003eProtease-resistant analogs\u003c\/strong\u003e, \u003cstrong data-start=\"8827\" data-end=\"8843\"\u003enanocarriers\u003c\/strong\u003e, and \u003cstrong data-start=\"8849\" data-end=\"8868\"\u003esmart hydrogels\u003c\/strong\u003e for sustained local delivery.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8901\" data-end=\"9070\"\u003e\n\u003cp data-start=\"8903\" data-end=\"9070\"\u003e\u003cstrong data-start=\"8903\" data-end=\"8931\"\u003ePhenotype-guided trials:\u003c\/strong\u003e Target \u003cstrong data-start=\"8939\" data-end=\"8972\"\u003ebiofilm-heavy, chronic wounds\u003c\/strong\u003e, \u003cstrong data-start=\"8974\" data-end=\"8995\"\u003eCF bronchiectasis\u003c\/strong\u003e, and \u003cstrong data-start=\"9001\" data-end=\"9031\"\u003erecalcitrant sinus disease\u003c\/strong\u003e with standardized biofilm endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9071\" data-end=\"9188\"\u003e\n\u003cp data-start=\"9073\" data-end=\"9188\"\u003e\u003cstrong data-start=\"9073\" data-end=\"9097\"\u003eCombination therapy:\u003c\/strong\u003e Synergy with \u003cstrong data-start=\"9111\" data-end=\"9146\"\u003eβ-lactams\/vancomycin\/quinolones\u003c\/strong\u003e to shorten courses and curb resistance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9189\" data-end=\"9328\"\u003e\n\u003cp data-start=\"9191\" data-end=\"9328\"\u003e\u003cstrong data-start=\"9191\" data-end=\"9214\"\u003eBiomarker strategy:\u003c\/strong\u003e Measure \u003cstrong data-start=\"9223\" data-end=\"9245\"\u003eLPS-neutralization\u003c\/strong\u003e, \u003cstrong data-start=\"9247\" data-end=\"9270\"\u003ecytokine signatures\u003c\/strong\u003e, and \u003cstrong data-start=\"9276\" data-end=\"9290\"\u003emicrobiome\u003c\/strong\u003e shifts alongside clinical outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9329\" data-end=\"9441\"\u003e\n\u003cp data-start=\"9331\" data-end=\"9441\"\u003e\u003cstrong data-start=\"9331\" data-end=\"9348\"\u003eSafety focus:\u003c\/strong\u003e Screen for \u003cstrong data-start=\"9360\" data-end=\"9385\"\u003eautoimmune flare risk\u003c\/strong\u003e (psoriasis history), optimize \u003cstrong data-start=\"9416\" data-end=\"9440\"\u003elocal dosing windows\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"9443\" data-end=\"9446\"\u003e\n\u003ch3 data-start=\"9448\" data-end=\"9471\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"9473\" data-end=\"10405\"\u003e\n\u003cli data-start=\"9473\" data-end=\"9623\"\u003e\n\u003cp data-start=\"9475\" data-end=\"9623\"\u003e\u003cstrong data-start=\"9475\" data-end=\"9553\"\u003eAntimicrobial Agents \u0026amp; Chemotherapy; Journal of Antimicrobial Chemotherapy\u003c\/strong\u003e — Antimicrobial and antibiofilm profiles, synergy with antibiotics.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9624\" data-end=\"9715\"\u003e\n\u003cp data-start=\"9626\" data-end=\"9715\"\u003e\u003cstrong data-start=\"9626\" data-end=\"9657\"\u003eInfection \u0026amp; Immunity; Shock\u003c\/strong\u003e — Endotoxin\/LTA neutralization and cytokine modulation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9716\" data-end=\"9851\"\u003e\n\u003cp data-start=\"9718\" data-end=\"9851\"\u003e\u003cstrong data-start=\"9718\" data-end=\"9774\"\u003eWound Repair \u0026amp; Regeneration; The Lancet EBioMedicine\u003c\/strong\u003e — Clinical signals in venous\/diabetic ulcers and tissue repair mechanisms.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9852\" data-end=\"9972\"\u003e\n\u003cp data-start=\"9854\" data-end=\"9972\"\u003e\u003cstrong data-start=\"9854\" data-end=\"9924\"\u003eAmerican Journal of Respiratory Cell and Molecular Biology; Thorax\u003c\/strong\u003e — Airway defence and inhaled peptide studies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9973\" data-end=\"10087\"\u003e\n\u003cp data-start=\"9975\" data-end=\"10087\"\u003e\u003cstrong data-start=\"9975\" data-end=\"10046\"\u003eJournal of Clinical Periodontology; Journal of Periodontal Research\u003c\/strong\u003e — Periodontal adjunctive therapy data.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10088\" data-end=\"10193\"\u003e\n\u003cp data-start=\"10090\" data-end=\"10193\"\u003e\u003cstrong data-start=\"10090\" data-end=\"10146\"\u003eInvestigative Ophthalmology \u0026amp; Visual Science; Cornea\u003c\/strong\u003e — LL-37 analogs in corneal infection\/repair.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10194\" data-end=\"10297\"\u003e\n\u003cp data-start=\"10196\" data-end=\"10297\"\u003e\u003cstrong data-start=\"10196\" data-end=\"10244\"\u003eNature Communications; Journal of Immunology\u003c\/strong\u003e — FPR2\/ALX signalling, immune tuning, NET biology.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"10298\" data-end=\"10405\"\u003e\n\u003cp data-start=\"10300\" data-end=\"10405\"\u003e\u003cstrong data-start=\"10300\" data-end=\"10329\"\u003eCancer Research; Oncogene\u003c\/strong\u003e — Context-dependent oncologic roles and tumor-selective analog development.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684853510482,"sku":null,"price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/LL-375mg.png?v=1770834862","url":"https:\/\/sciencepeptideslab.com\/products\/ll-37-5mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}